相关实验视频
Updated: Jul 24, 2025

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
274
对于阿尔茨海默病的新兴纳米技术:从检测到治疗
1Department of Physics, School of Science, Tianjin Chengjian University, Tianjin 300384, China.
概括
纳米技术为阿尔茨海默病 (AD) 提供了有希望的解决方案,这是一个复杂的神经退行性疾病. 本综述探讨了纳米粒子 (NP) 如何促进早期检测和AD的新疗法,解决当前的挑战.
科学领域:
- 神经科学是一个神经科学.
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
背景情况:
- 阿尔茨海默病 (AD) 是一种流行的神经退行性疾病,其特征是认知能力下降和病理特征,如粉样β (Aβ) 斑块和团.
- 阿尔茨海默病的复杂而往往模两可的病原体对早期诊断和有效治疗提出了重大挑战.
- 纳米粒子 (NP) 具有独特的特性,使其非常适合开发AD的先进诊断和治疗策略.
研究的目的:
- 审查用于阿尔茨海默病检测纳米技术的最新进展.
- 为了突出纳米技术为AD的基于治疗干预的进展.
- 要总结当前的挑战和未来的前景在纳米诊断和纳米治疗阿尔茨海默病.
主要方法:
- 通过使用电化学,光学和成像技术检测AD的纳米技术应用现有文献的综述.
- 分析基于纳米技术的治疗方法,包括生物标志物向,干细胞治疗和AD的免疫治疗.
- 综合有关在AD纳米医学的挑战和未来方向的信息.
主要成果:
- 纳米技术,特别是使用NP,在通过各种传感和成像方式提高早期发现AD方面显示出巨大的潜力.
- 基于纳米技术的阿尔茨海默氏症治疗方法正在出现,重点是针对疾病生物标志物的向传递,以及干细胞治疗和免疫治疗的进步.
- 尽管取得了进展,但在临床转化和AD纳米诊断和纳米治疗的广泛应用方面仍然存在挑战.
结论:
- 纳米技术为改善阿尔茨海默病诊断和治疗策略提供了创新工具.
- 纳米医学的持续研究和开发对于克服当前挑战和实现纳米技术在管理AD的全部潜力至关重要.
- 纳米技术的整合为针对阿尔茨海默病的个性化和有效干预提供了有希望的未来.
相关概念视频
Alzheimer's Disease: Treatment
220
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
220
Alzheimer's Disease: Overview
527
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
527
Dementia
141
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
141

